Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (391-400 of 568) with videos related to

Pageof 57
Sort By:
Frontiers in Medicine|October 3, 2022
Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management expertsMiguel Montoro, Mercedes Cucala, Ángel Lanas, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Digestive Diseases and Sciences|December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose EscalationCarlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Journal of Clinical Medicine|June 24, 2022
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of <i>Helicobacter</i><i>pylori</i> Infection (Hp-EuReg)Luis Fernández-Salazar, Ana Campillo, Luis Rodrigo, et al.
Gastroenterologia Y Hepatologia|June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
BMC Medicine|September 10, 2016
Urine metabolome profiling of immune-mediated inflammatory diseasesArnald Alonso, Antonio Julià, Maria Vinaixa, et al.
Gastroenterologia Y Hepatologia|December 3, 2019
Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in SpainIgnasi Puig, Erwin Sanabria, Faust Feu, et al.
Swiss Medical Weekly|August 14, 2025
Effectiveness and safety of first-line empirical Helicobacter pylori eradication regimens in Switzerland: an interim analysis from a prospective multicentre registry (Hp-EuReg)Michael Doulberis, Daniele Riva, Ioannis Linas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel DiseaseLaurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
Gastroenterologia Y Hepatologia|July 5, 2011
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experienceJosé Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, et al.
Pageof 57

Showing results (391-400 of 568) with videos related to

Sort By:
Pageof 57
Frontiers in Medicine|October 3, 2022
Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management expertsMiguel Montoro, Mercedes Cucala, Ángel Lanas, et al.
Antibiotics (Basel, Switzerland)|September 28, 2021
Antibiotic Resistance Prevalence and Trends in Patients Infected with <i>Helicobacter pylori</i> in the Period 2013-2020: Results of the European Registry on <i>H. pylori</i> Management (Hp-EuReg)Luis Bujanda, Olga P Nyssen, Dino Vaira, et al.
Digestive Diseases and Sciences|December 21, 2016
Adalimumab Maintenance Treatment in Ulcerative Colitis: Outcomes by Prior Anti-TNF Use and Efficacy of Dose EscalationCarlos Taxonera, Eva Iglesias, Fernando Muñoz, et al.
Journal of Clinical Medicine|June 24, 2022
Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of <i>Helicobacter</i><i>pylori</i> Infection (Hp-EuReg)Luis Fernández-Salazar, Ana Campillo, Luis Rodrigo, et al.
Gastroenterologia Y Hepatologia|June 26, 2016
IV Spanish Consensus Conference on Helicobacter pylori infection treatmentJavier P Gisbert, Javier Molina-Infante, Javier Amador, et al.
BMC Medicine|September 10, 2016
Urine metabolome profiling of immune-mediated inflammatory diseasesArnald Alonso, Antonio Julià, Maria Vinaixa, et al.
Gastroenterologia Y Hepatologia|December 3, 2019
Heterogeneity of clinical management of low-grade gastric lymphoma of mucosa-associated lymphoid tissue. An audit of 198 patients in SpainIgnasi Puig, Erwin Sanabria, Faust Feu, et al.
Swiss Medical Weekly|August 14, 2025
Effectiveness and safety of first-line empirical Helicobacter pylori eradication regimens in Switzerland: an interim analysis from a prospective multicentre registry (Hp-EuReg)Michael Doulberis, Daniele Riva, Ioannis Linas, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2022
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel DiseaseLaurent Peyrin-Biroulet, Jean-François Rahier, Julien Kirchgesner, et al.
Gastroenterologia Y Hepatologia|July 5, 2011
Adalimumab is effective in long-term real life clinical practice in both luminal and perianal Crohn's disease. The Madrid experienceJosé Ignacio Fortea-Ormaechea, Yago González-Lama, Begoña Casis, et al.
Pageof 57